O’Ryan.Health, a leader in at-home pediatric healthcare innovation, today announced it has become the first US company to launch two, parent-led observational studies “The Healthy Kids Study” and “The JDM Study,” involving the in-home collection of pediatric blood from children. Juvenile Dermatomyositis (JDM) is an ultra-rare pediatric autoimmune disorder. These studies, made possible through a partnership with YourBio Health, a pioneer in capillary blood sampling, allow parents to safely and efficiently sample their children’s blood without having to travel to a medical facility.
The number of doctors and experts that bridge the gap between university research and the NHS – translating discoveries into patient care – is "ageing and shrinking", the Academy of Medical Sciences has warned.
The UK's life sciences industry generated £146.9bn in…
A new machine learning tool developed by researchers at the Queensland Institute of Medical Research Berghofer can help pathologists identify subtle cancer biomarkers in standard tissue samples.
The tool, called STimage, applies spatial analysis to hematoxylin and eosin-stained (H&E) tissue…